FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051885011> ?p ?o ?g. }

• W2051885011 endingPage "628" @default.
• W2051885011 startingPage "622" @default.
• W2051885011 abstract "In this report we investigated the combination of epidermal growth factor receptor (EGFR) and mammalian target of rapamycin (mTOR) pathway inhibition as a possible new therapeutic strategy for small cell lung cancer (SCLC).EGFR, p-AKT, p-ERK, p-mTOR and p-p70s6K protein expressions were studied by immunohistochemistry in 107 small cell lung carcinomas and correlated with clinicopathological parameters. Cells of SCLC were treated with erlotinib+/-RAD001 and analysed for cell viability, proliferation, autophagy, and pathway regulation.Epidermal growth factor receptor, p-AKT, p-ERK, p-mTOR, and p-p70s6K were expressed in 37, 24, 13, 55 and 91% of the tumour specimens of all SCLC patients, respectively, and were not associated with disease-free or overall survival. The expression of EGFR was lower in neoadjuvant-treated patients (P=0.038); mTOR pathway activation was higher in the early stages of disease (P=0.048). Coexpression of EGFR/p-mTOR/p-p70s6K was observed in 28% of all patients . EGFR immunoreactivity was associated with p-ERK and p-mTOR expression (P=0.02 and P=0.0001); p-mTOR immunoreactivity was associated with p-p70s6K expression (P=0.001). Tumour cells comprised a functional EGFR, no activating mutations in exons 18-21, and resistance to RAD001 monotherapy. We found synergistic effects of erlotinib and RAD001 combination therapy on the molecular level, cell viability, proliferation and autophagy.The combined inhibition of EGFR/mTOR pathways could be a promising approach to treat SCLC." @default.
• W2051885011 created "2016-06-24" @default.
• W2051885011 creator A5030453966 @default.
• W2051885011 creator A5036486301 @default.
• W2051885011 creator A5043913136 @default.
• W2051885011 creator A5050872462 @default.
• W2051885011 creator A5052232078 @default.
• W2051885011 creator A5063300935 @default.
• W2051885011 creator A5067100324 @default.
• W2051885011 creator A5084907442 @default.
• W2051885011 creator A5086608796 @default.
• W2051885011 creator A5090118471 @default.
• W2051885011 date "2010-08-01" @default.
• W2051885011 modified "2023-10-08" @default.
• W2051885011 title "Dual inhibition of EGFR and mTOR pathways in small cell lung cancer" @default.
• W2051885011 cites W1980102456 @default.
• W2051885011 cites W1989444090 @default.
• W2051885011 cites W2004074769 @default.
• W2051885011 cites W2011322082 @default.
• W2051885011 cites W2017018900 @default.
• W2051885011 cites W2023888914 @default.
• W2051885011 cites W2036834298 @default.
• W2051885011 cites W2038598054 @default.
• W2051885011 cites W2042377836 @default.
• W2051885011 cites W2043696829 @default.
• W2051885011 cites W2059890247 @default.
• W2051885011 cites W2073124245 @default.
• W2051885011 cites W2079399000 @default.
• W2051885011 cites W2081167500 @default.
• W2051885011 cites W2081495762 @default.
• W2051885011 cites W2104135961 @default.
• W2051885011 cites W2104380111 @default.
• W2051885011 cites W2109566248 @default.
• W2051885011 cites W2111065680 @default.
• W2051885011 cites W2118677643 @default.
• W2051885011 cites W2125887187 @default.
• W2051885011 cites W2126783165 @default.
• W2051885011 cites W2135117965 @default.
• W2051885011 cites W2135836172 @default.
• W2051885011 cites W2140238752 @default.
• W2051885011 cites W2153867442 @default.
• W2051885011 cites W2157824687 @default.
• W2051885011 cites W2165654457 @default.
• W2051885011 cites W2170088667 @default.
• W2051885011 cites W2261812292 @default.
• W2051885011 cites W4244670171 @default.
• W2051885011 doi "https://doi.org/10.1038/sj.bjc.6605761" @default.
• W2051885011 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2938245" @default.
• W2051885011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20683448" @default.
• W2051885011 hasPublicationYear "2010" @default.
• W2051885011 type Work @default.
• W2051885011 sameAs 2051885011 @default.
• W2051885011 citedByCount "60" @default.
• W2051885011 countsByYear W20518850112012 @default.
• W2051885011 countsByYear W20518850112013 @default.
• W2051885011 countsByYear W20518850112014 @default.
• W2051885011 countsByYear W20518850112015 @default.
• W2051885011 countsByYear W20518850112016 @default.
• W2051885011 countsByYear W20518850112017 @default.
• W2051885011 countsByYear W20518850112018 @default.
• W2051885011 countsByYear W20518850112019 @default.
• W2051885011 countsByYear W20518850112020 @default.
• W2051885011 countsByYear W20518850112021 @default.
• W2051885011 countsByYear W20518850112022 @default.
• W2051885011 countsByYear W20518850112023 @default.
• W2051885011 crossrefType "journal-article" @default.
• W2051885011 hasAuthorship W2051885011A5030453966 @default.
• W2051885011 hasAuthorship W2051885011A5036486301 @default.
• W2051885011 hasAuthorship W2051885011A5043913136 @default.
• W2051885011 hasAuthorship W2051885011A5050872462 @default.
• W2051885011 hasAuthorship W2051885011A5052232078 @default.
• W2051885011 hasAuthorship W2051885011A5063300935 @default.
• W2051885011 hasAuthorship W2051885011A5067100324 @default.
• W2051885011 hasAuthorship W2051885011A5084907442 @default.
• W2051885011 hasAuthorship W2051885011A5086608796 @default.
• W2051885011 hasAuthorship W2051885011A5090118471 @default.
• W2051885011 hasBestOaLocation W20518850111 @default.
• W2051885011 hasConcept C121608353 @default.
• W2051885011 hasConcept C126322002 @default.
• W2051885011 hasConcept C142724271 @default.
• W2051885011 hasConcept C170493617 @default.
• W2051885011 hasConcept C190283241 @default.
• W2051885011 hasConcept C203522944 @default.
• W2051885011 hasConcept C2776256026 @default.
• W2051885011 hasConcept C2776362946 @default.
• W2051885011 hasConcept C2777921159 @default.
• W2051885011 hasConcept C2778087573 @default.
• W2051885011 hasConcept C2779438470 @default.
• W2051885011 hasConcept C502942594 @default.
• W2051885011 hasConcept C54355233 @default.
• W2051885011 hasConcept C55493867 @default.
• W2051885011 hasConcept C57074206 @default.
• W2051885011 hasConcept C62112901 @default.
• W2051885011 hasConcept C62478195 @default.
• W2051885011 hasConcept C71924100 @default.
• W2051885011 hasConcept C75217442 @default.
• W2051885011 hasConcept C86554907 @default.
• W2051885011 hasConcept C86803240 @default.

• next